Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Florencia Giraudo

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Pathogens & Immunity|March 29, 2024
Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin's LymphomaMaria Florencia Giraudo, Zachary Jackson, Indrani Das, et al.
Cancer Discovery|May 13, 2022
Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin LymphomaZachary Jackson, Changjin Hong, Robert Schauner, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Pathogens & Immunity|March 29, 2024
Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin's LymphomaMaria Florencia Giraudo, Zachary Jackson, Indrani Das, et al.
Cancer Discovery|May 13, 2022
Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin LymphomaZachary Jackson, Changjin Hong, Robert Schauner, et al.
Pageof 1